Ventavis — Cigna
Pulmonary arterial hypertension (WHO Group 1)
Preferred products
- Tyvaso
- Tyvaso DPI
Initial criteria
- Patient meets the standard Pulmonary Arterial Hypertension – Inhaled Prostacyclin Products Prior Authorization Policy criteria; AND
- Patient meets ONE of the following (i, ii, or iii):
- i. Patient has been established on Ventavis; OR
- ii. Patient has tried Tyvaso or Tyvaso DPI; OR
- iii. Patient already has the device for Ventavis.
Approval duration
1 year